Democrats Seek GAO Probe of Gilead’s Covid Treatment Remdesivir

U.S. House Oversight Cmte Chair Carolyn Maloney and Sen. Debbie Stabenow ask the Government Accountability Office to investigate the discovery and development of Gilead’s remdesivir.

• Gilead announced it will charge govt programs $390 per vial, or $2,340 per five-day treatment of the drug, joint statement says
• “Because of the high price,” the lawmakers are asking GAO to also examine what legal rights federal agencies have related to their contributions to the discovery and development of remdesivir: statement
• Link to letter
• NOTE: Stabenow is top Democrat on Senate Finance Cmte health panel

To contact the reporter on this story:
Kim ...